KRT17 and cancer: Expression of KRT17 has been described in bladder carcinoma, keratoacanthoma and squamous cell carcinoma, oral squamous cell carcinoma, premalignant and malignant squamous lesions of the cervix, all derived from multilayer epithelial cells 7-10.